Table 4.
Characteristic | Hazard Ratio | 95% CI | P Value |
---|---|---|---|
1‐y mortalitya | |||
Age | 1.06 | 1.02 to 1.09 | 0.001 |
AHR <60 bpm vs 60 to 79 bpm | 1.33 | 0.41 to 4.34 | 0.64 |
AHR 80 to 99 bpm vs 60 to 79 bpm | 1.69 | 0.67 to 4.28 | 0.27 |
AHR ≥100 bpm vs 60 to 79 bpm | 5.02 | 1.95 to 12.88 | 0.0008 |
Left ventricular ejection fraction <40% | 5.61 | 2.54 to 12.40 | <0.0001 |
Cardiogenic shock | 6.33 | 1.84 to 21.72 | 0.003 |
1‐y major adverse cardiac eventsa | |||
History of congestive heart failure | 2.61 | 1.21 to 5.63 | 0.01 |
AHR <60 bpm vs 60 to 79 bpm | 1.08 | 0.62 to 1.88 | 0.78 |
AHR 80 to 99 bpm vs 60 to 79 bpm | 0.87 | 0.54 to 1.40 | 0.57 |
AHR ≥100 bpm vs 60 to 79 bpm | 2.20 | 1.29 to 3.75] | 0.004 |
Left ventricular ejection fraction <40% | 2.50 | 1.43 to 4.37 | 0.0013 |
Cardiogenic shock | 7.13 | 2.71 to 18.75 | <0.0001 |
The following covariates were included in the multivariable analyses: age, previous myocardial infarction, diabetes mellitus, congestive heart failure, left ventricular ejection fraction <40%, cardiogenic shock, AHR range, and β‐blocker use on admission. Covariates not presented in the final model were non–statistically significant. AHR indicates admission heart rate; bpm, beats per minute; RCA, right coronary artery.
AHR 60 to 79 bpm was used as reference.